Okmeydani Training and Research Hospital of the Ministry of Health

İstanbul, Turkey

Okmeydani Training and Research Hospital of the Ministry of Health

İstanbul, Turkey
SEARCH FILTERS
Time filter
Source Type

Yildiz O.,Erciyes University | Aygen B.,Erciyes University | Demirturk N.,Afyon Kocatepe University | Demirdal T.,Afyon Kocatepe University | And 4 more authors.
World Journal of Gastroenterology | Year: 2011

AIM: To determine the distribution of viral genotypes for primary or acquired lamivudine resistance. METHODS: A total of 283 patients with chronic hepatitis B virus (HBV) infection (245 patients with chronic hepatitis B and 38 inactive hepatitis B surface antigen carriers) were included in the study. The HBV genotype was determined by using quantitative real-time polymerase chain reaction and sequence analysis, and tyrosine-methionine-aspartate-aspartate (YMDD) motif mutations were determined using the reverse transcriptase hybridization method. RESULTS: Lamivudine resistance was determined in a total of 25 (10.7%) chronic hepatitis B patients. Eight subjects (4%) had primary resistance to lamivudine, and 17 (53.1%) had secondary resistance to lamivudine. Genotype D, which was isolated from 267 of the patients with chronic HBV infection, was the dominant genotype in Turkey. CONCLUSION: Identification of YMDD motif mutations should have a positive impact on the selection of proper antiviral medication for patients, even for those who are nucleoside naïve. © 2011 Baishideng. All rights reserved.

Loading Okmeydani Training and Research Hospital of the Ministry of Health collaborators
Loading Okmeydani Training and Research Hospital of the Ministry of Health collaborators